Conservative LeverageA low-debt balance sheet reduces financial risk and refinancing pressure, providing stability and flexibility in strategic planning.

Shareholder SupportStrong shareholder support at the AGM indicates confidence in management and strategic direction, potentially aiding future governance.

Strategic OpportunitiesExploring strategic opportunities can unlock shareholder value and improve financial strategy, enhancing long-term business prospects.

Bears Say

Revenue VolatilityExtreme revenue volatility and near-zero levels indicate weak commercialization, posing challenges to achieving sustainable growth.

Negative Cash FlowPersistent negative cash flow highlights a cash-burning profile, necessitating external funding and impacting long-term financial health.

Clinical SetbacksClinical setbacks can delay product development and commercialization, affecting the company's ability to generate future revenue.

Hexima Ltd News

Hexima Preserves $1.4m Cash as It Weighs Capital Return to Shareholders

Hexima Ltd ( ($AU:HXL) ) has issued an announcement. Hexima Limited reported a cash balance of $1.4 million...

6d ago

HXL

ASX Warns Long-Term Suspended Companies of Reporting Deadlines and Delisting Risk

An announcement from Hexima Ltd ( ($AU:HXL) ) is now available. The Australian Securities Exchange has published an...

14d ago

HXL

Hexima Ltd Announces Successful AGM Results

An update from Hexima Ltd ( ($AU:HXL) ) is now available. Hexima Ltd announced the results of its...

2M ago

HXL

Hexima Ltd Outlines Future Amidst Clinical Setbacks

The latest announcement is out from Hexima Ltd ( ($AU:HXL) ). Hexima Ltd’s Chair addressed the company’s current...

2M ago

HXL

Hexima Limited Explores Strategic Opportunities Amid Quarterly Financial Update

Hexima Ltd ( ($AU:HXL) ) has provided an update. Hexima Limited reported a cash balance of $1.44 million...

3M ago

HXL

Hexima Limited Announces 2025 AGM Details

The latest update is out from Hexima Ltd ( ($AU:HXL) ). Hexima Limited, listed on the ASX under...

3M ago

HXL

Hexima Limited Announces 2025 AGM and Director Nominations

An announcement from Hexima Ltd ( ($AU:HXL) ) is now available. Hexima Limited has announced that its 2025...

5M ago

HXL

Hexima Limited Reports Quarterly Financials with Stable Cash Position

Hexima Ltd ( ($AU:HXL) ) has shared an announcement. Hexima Limited reported a cash balance of $1.54 million...

6M ago

HXL

ASX Suspends Long-Term Non-Compliant Entities

Hexima Ltd ( ($AU:HXL) ) just unveiled an update. The Australian Securities Exchange (ASX) has announced the suspension...

7M ago

HXL

Hexima Limited Reports Quarterly Financials with Strategic Focus

Hexima Ltd ( ($AU:HXL) ) has shared an announcement. Hexima Limited, an Australian company listed on the ASX,...

9M ago

HXL

HXL FAQ

What was Hexima Ltd’s price range in the past 12 months?

Hexima Ltd lowest share price was AU$0.01 and its highest was AU$0.01 in the past 12 months.

What is Hexima Ltd’s market cap?

Hexima Ltd’s market cap is AU$2.17M.

When is Hexima Ltd’s upcoming earnings report date?

Hexima Ltd’s upcoming earnings report date is Feb 26, 2026 which is in 21 days.

How were Hexima Ltd’s earnings last quarter?

Hexima Ltd released its earnings results on Aug 29, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.

Is Hexima Ltd overvalued?

According to Wall Street analysts Hexima Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Hexima Ltd pay dividends?

Hexima Ltd does not currently pay dividends.

What is Hexima Ltd’s EPS estimate?

Hexima Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hexima Ltd have?

Hexima Ltd has 167,039,630 shares outstanding.

What happened to Hexima Ltd’s price movement after its last earnings report?

Hexima Ltd reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Hexima Ltd?

Currently, no hedge funds are holding shares in AU:HXL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Hexima Ltd Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

-28.49%

Trailing 12-Months

Asset Growth

-31.37%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Hexima Ltd

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.